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Per and poly fluoroalkyl substances 
A B S T R A C T   
Background: Residents of Anniston Alabama were highly exposed to polychlorinated biphenyls (PCBs) due to 
longstanding manufacturing in the area. The Anniston Community Health Surveys (ACHS I-2005–2007 and II, 
2014) have linked these exposures with a variety of deletereous health outcomes. In addition to PCBs, these 
individuals were likely simultaneously exposed to other persistent organic pollutants including per and poly-
fluoroalkyl substances (PFAS), which are an emerging class of ubiquitous industrial chemicals that are 
measurable in the blood of most individuals and have themselves been linked increased risk of some non 
communicable diseases. 
Methods: To characterize PFAS exposures in ACHS I and ACHS II, we measured eight environmentally significant 
PFAS in serum by UPLC coupled electrospray ionization tandem mass spectrometry. Perfluorooctane sulfonate 
(PFOS), Perfluorooctanoic acid (PFOA), Perfluorononanoate (PFNA), Perfluorohexane sulfonate (PFHxS), Per-
fluoroheptanoic acid (PFHpA), Perfluorobutanesulfonic acid (PFBS), Hexafluoropropylene oxide dimer acid 
(HFPO-DA), and 4:2 Fluorotelomer sulfonic acid (4.2 FTS) were extracted from matched serum samples of in-
dividuals who participated in the original ACHS I (2005–2007; n = 297) and the follow up ACHS II (2014; n =
336). Data were collected in negative multiple reaction monitoring (MRM) mode with monitoring of quantitation 
and qualifier ions for all target PFAS analytes, surrogates and internal standards. VARCLUS procedure was used 
to create hierarchical clusters between PFAS and other legacy persistent organic pollutants which may share 
similar exposure routes. 
Results: Overall, circulating PFAS levels decreased approximately 50% from ACHS I (2005–2007) to ACHS II 
(2014), but these changes varied by compound. Mean levels of PFOS were >3 times higher in ACHS I subjects 
than in conpemporaneous NHANES subjects (2005–2006; ACHS I mean: 71.1 ng/ml; NHANES mean: 20.2 ng/ 
mL), and this relationship persisted in ACHS II subjects (2014: ACHS II mean: 34.7 ng/ml; NHANES mean: 5.92 
ng/mL). PFNA was also higher in both ACHS I and ACHS II subjects in comparision to NHANES whereas levels of 
PFOA and PFHxS were lower than in NHANES. Finally, cluster analysis revealed that in ACHS II, most PFAS 
tracked with polybrominated diphenyl ethers, except PFNA and PFHpA which clustered with industrial PCBs. In 
ACHS I, PFAS analytes correlated more closely with industrial PCBs and chlorinated pesticides. 
Conclusions: Participants in the Anniston Community Health Surveys have higher levels of PFOS and PFNA than 
the general population with average PFOS levels >3 times contemporaneous NHANES levels. Since PFAS were 
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not known to be manufactured in the area, more work needs to be completed to determine if population de-
mographics, proximity to a military base, or regional manufacturing can explain the elevated levels.   
1. Introduction 
Per- and polyfluoroalkyl substances (PFAS) are a class of ubiquitous 
man-made chemicals utilized for their surfactant properties in cook-
ware, clothing, and carpets as well as in aqueous film forming foams 
used by civilian and military firefighters (ATSDR, 2020). Approximately 
7000 chemically distinct PFAS have been reported in the chemical 
literature with a smaller subset of these found in the environment. 
Exposure to a handful of widely distributed PFAS have been associated 
with chronic diseases including steatosis, cardiometabolic disorders, 
and cancers, as well as endocrine disruption, reproductive and devel-
opmental impacts, elevated lipids, and obesity in epidemiological 
studies (ATSDR, 2020). Although long-chain legacy PFAS such as Per-
fluorooctanesulfonic acid (PFOS) and Perfluorooctanoic Acid (PFOA) 
have begun to be replaced by emerging PFAS of shorter chain length (e. 
g., Hexafluoropropylene oxide dimer acid; HFPO-DA), mixtures of these 
legacy and emerging PFAS are evident in the environment and have 
been found at differing levels circulating in human blood (Sunderland 
et al., 2019). Using data collected over time from longitudinal studies, 
long-chain PFAS have estimated half-lives within the human body of 
multiple years which is comparable to other well studied persistent 
organic pollutants, such as dioxins and polychlorinated biphenyls (Fu, 
2016). The toxicokinetics and distribution of PFAS differ from other 
legacy pollutants however, as PFAS are more likely to continuously 
circulate throughout the bloodstream bound to albumin instead of being 
sequestered in adipose tissue (Han et al., 2003; Salvalaglio et al., 2010). 
The purpose of this study was to address a current deficiency in the 
literature by making longitudinal measurements of PFAS and other 
persistent organic pollutants (POPs) in the same individuals. Data of this 
type are currently lacking and may be a useful measure of how back-
ground levels have changed since legacy PFAS began to be phased out of 
production during the early 2000s. 
The original Anniston Community Health Survey (ACHS I) was 
completed during 2005–2007 and included volunteers residing in 
Anniston, Alabama which was a site of polychlorinated biphenyl (PCB) 
production from 1929 to 1971. Using clinical data and measurements of 
circulating levels of 35 PCBs, epidemiological studies have shown links 
between exposure to these persistent organic pollutants and multiple 
disease pathologies/risk factors including hypertension, endocrine 
disruption, liver disease and diabetes (Goncharov et al., 2010; Silver-
stone et al., 2012; Clair et al., 2018; Rosenbaum et al., 2017). Building 
on these initial reports, a follow-up study took place in 2014 (ACHS II) 
which included measurement of the original 35 PCBs as well as addi-
tional measurements of dioxin-like pollutants and pesticides in surviving 
participants of ACHS (Yang et al., 2018). Using these newly collected 
results, we and others have thus far shown associations between 
persistent organic pollutant (POP) exposure and markers of car-
diometabolic disease (i.e., Trimethylamine N-oxide) and hypertension 
(Petriello et al., 2018; Pavuk et al., 2019; Pavuk et al., 2014). Although 
quantitating PFAS was not a primary goal of either ACH survey (PFAS 
was not known to be manufactured in Anniston, Alabama and the area 
was not a known region of abundant water contamination), the longi-
tudinal nature of the study and additional high quality pollutant mea-
surements make the ACH surveys prime cohorts to study changes in long 
chain and short chain PFAS over time and to examine how PFAS levels 
relate to circulating levels of other persistent organic pollutants. Addi-
tionally, these cohorts are useful because samples were collected for 
ACHS I around the time that commercial use of some PFAS, especially 
PFOS, began to be discontinued and so may represent a high point for 
legacy PFAS bioaccumulation among the general public of the United 
States (Olsen et al., 2017). Therefore, the purpose of this present study 
was to measure a panel of representative legacy and short chain PFAS in 
samples collected from ACHS II and compare levels collected from the 
same individuals approximately a decade earlier to observe changes 
over time. Secondary goals of this study were to (1) examine if levels of 
PFAS were similar to those of the general adult population by comparing 
to corresponding NHANES data, and (2) to identify any significant 
correlations with other persistent organic pollutants and determine if 
these associations differed over time. 
2. Methods 
2.1. Description of cohort 
Anniston Alabama, a city located between Atlanta, Georgia and 
Birmingham, Alabama was a major site of PCB manufacturing and 
environmental discharges from 1929 to 1971. To determine levels of 
PCBs in this population and to investigate associations with disease risk, 
the initial Anniston Community Health Survey (ACHS I) began in 2005 
and recruited 774 volunteers who provided blood samples and de-
mographic/clinical information (Pavuk et al 2014). Briefly, participants 
were 46% African American, middle aged (mean 54 years, 
range:19–79), and 70% female. In 2014, remaining surviving and 
available individuals from ACHS I were re-consented for a follow-up 
study (ACHS II; n = 359) and provided an additional blood sample 
and updated demographic/clinical information. Demographics were 
similar to the initial study, but ACHS II enrolled 53% African Americans 
and were obviously older (age range 26–87) (Birnbaum et al., 2016). 
Based on availability, samples from 297 individuals of ACHS I and 336 
from ACHS II were shipped to the University of Kentucky for PFAS an-
alyses. Both long chain (i.e., PFNA, PFOA, PFOS, PFHxS, PFHpA) and 
short chain (i.e., PFBS, HFPO-DA, and 4.2 FTS) PFAS were measured in 
ACHS I and ACHS II; Long chain sulfonic acids were categorized by chain 
lengths greater or equal to 6 and long chain carboxylic acids were 
categorized by chain lengths greater or equal to 7. 
2.2. PFAS extraction and quantitation 
PFAS were extracted and analyzed as previously described (Mottaleb 
et al., 2020). Briefly, 50 µL of serum was extracted in 96-well Impact 
Protein Precipitation Plates (Phenomenex, CA, USA) using methanol 
with addition of known concentrations of 13C labeled PFAS (13C-PFOS, 
13C-PFOA, 13C -PFNA and 13C-PFHxS, Wellington Laboratories, Guelph, 
ON) as internal standards and surrogates. Dried extracts were recon-
stituted in ammonium acetate that contained 3.0 ng/mL of 13C4–PFHpA 
as internal standard. All extraction plates contained reagent blank (R- 
BLK), IS (internal standard)-blank and quality control samples. PFAS 
were quantitated by UHPLC-MS/MS using a Shimadzu ultra- 
performance liquid chromatography system (UPLC; model: Nexra X2 
LC 30 AD) coupled to a Sciex QTRAP mass spectrometer (MS; model: 
Sciex 6500 plus) operated in negative ionization multiple reaction 
monitoring (MRM) mode. Parent and product ions for all PFAS, surro-
gates, and IS as well as instrument settings, and analytical method 
performance parameters have been reported previously (Mottaleb et al., 
2020). PFAS were quantitated using IS-based calibration curves with 
lower limits of quantitation between 0.04 ng/mL and 0.20 ng/mL and 
are again reported here in the supplement (Mottaleb et al., 2020). The 
assay performance in this particular study was identical to that we have 
previously reported. Before analysis, we verified that the sensitivity of 
the instrument met or exceeded the manufacturer’s specifications and 
we used blanks and in batch samples containing low, medium and high 
analyte levels to monitor instrument performance. With regular 
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cleaning, verification of sensitivity and use of a dedicated UHPLC system 
the assay performance consistently resulted in CVs of <10% for repeated 
analysis of these in batch controls. 
2.3. Data and statistical analyses 
Data analyses was performed using JMP® Pro, Version 14.0. (SAS 
Institute Inc., Cary, NC). For PFAS concentrations below the limit of 
quantitation, values were calculated as LOD/√2. Initially, descriptive 
statistics including mean, median, and variance were determined for all 
available ACHS I (n = 297) and ACHS II (n = 336) samples. To deter-
mine if PFAS differed over time, PFAS values were log transformed (x +
1), matched pairs analysis was completed (n = 294), and P-values cor-
responding to 2-tailed t-tests between the matched pairs were deter-
mined. To compare levels of circulating PFAS to those of the general 
public, corresponding NHANES 2005–2006 and NHANES 2013–2014 
PFAS datasets were downloaded from the Inter-university Consortium 
for Political and Social Research (ICPSR) website curated by University 
of Michigan or CDC website. NHANES samples with available de-
mographic and PFAS concentration data were used for subsequent an-
alyses with NHANES. Significant differences between ACHS I and 
NHANES 2005–2006 as well as between ACHS II and NHANES 
2013–2014 were determined using mean and median tests when data 
were stratified by sex, race, and age. We consider a p-value <0.05 as 
significant. 
Finally, to determine if PFAS concentrations correlated with other 
pollutants measured, including PCBs, dioxins, pesticides, and PBDEs, we 
performed correlation and hierarchical cluster analyses for ACHS II (n =
287) and ACHS I data (n = 292; those that also participated in ACHS-I) 
(Anderberg, 1973; Hand et al., 1994). Correlation analyses addressed 
the question of whether there is linear relationship between PFAS and 
other POPs. The cluster analyses used the linear relationship combina-
tions in a different way complementing the correlation analyses. The 
purpose of cluster analysis is to place objects into groups, or clusters, 
suggested by the data, not defined a priori (e.g. by chemical structure). 
Generally, objects in each cluster tend to be similar to each other in some 
sense, and objects in different clusters tend to be dissimilar. We used the 
VARCLUS procedure to create hierarchical clusters as some exposure 
variables (e.g., PCBs) are highly correlated. VARCLUS procedure divides 
a set of numeric variables into hierarchical clusters with a linear com-
bination of the variables in the cluster (CLUSTER procedure uses dis-
tances). This linear combination can be either the first principal 
component (used in this analyses) or the centroid component; Both 
options provided similar clustering results (number of clusters and 
components of the clusters). The cluster analysis maximizes the variance 
that is explained by the cluster components summed over all clusters 
using principal components which are the weighted average of the 
variables that explains as much variance as possible. Unlike principal 
component analysis, this procedure is oblique, meaning that each cluster 
component is computed from a different set of variables than all the 
other cluster components (Harman, 1976). This algorithm is both divi-
sive and iterative and will continue splitting groups until every cluster 
has only one eigenvalue greater than one (Harris and Kaiser, 1964). Non 
log-transformed whole weight exposure variables for PCBs, pesticides, 
and dioxin-like compounds were used for the cluster analysis with PFAS. 
Pearson’s correlation coefficients were calculated for basic correlation 
tables to contrast with hierarchical cluster analyses. 
3. Results 
3.1. PFAS concentrations and change over time 
Levels of the indicated PFAS in samples from ACHS I (2005–2007) 
were as follows: PFOS (mean; 71.1 ng/mL) > PFHxS (mean; 2.35 ng/ 
mL) > PFOA (mean; 2.16 ng/mL) > PFNA (mean; 1.69 ng/mL) > PFHpA 
(mean; 0.30 ng/mL) > PFBS (mean; 0.05 ng/mL) = HFPO-DA (mean; 
0.05 ng/mL) = 4.2 FTS (mean; 0.05 ng/mL) (Table 1). Levels of legacy 
long chain PFAS such as PFOS and PFOA were found in nearly all in-
dividuals, but short chain PFAS were not widely detected (e.g., HFPO- 
DA only quantitated in 4.4% of individuals; LOD = 0.05 ng/mL). In 
samples collected in ACHS II (2014), levels of individual PFAS generally 
declined, but the ratio of abundance was similar to that of ACHS I. 
However, HFPO-DA was now the most abundant short chain PFAS, but 
again, was not widely detected (HFPO-DA only above LOD in 8.9% of 
individuals). The percent above LOD for each PFAS is shown in Table 1. 
Levels of the indicated PFAS in samples from ACHS II were as follows: 
PFOS (mean; 34.7 ng/mL) > PFHxS (mean; 1.62 ng/mL) > PFOA (mean; 
1.16 ng/mL) > PFNA (mean; 1.04 ng/mL) > PFHpA (mean; 0.13 ng/ 
mL) > HFPO-DA (mean; 0.07 ng/mL) > PFBS (mean; 0.05 ng/mL) > 4.2 
FTS (mean; 0.04 ng/mL) (Table 1). Levels of these short chain com-
pounds were close to the limit of detection of our analytical method. The 
skewness of each PFAS differed, with PFOA appearing most normally 
distributed. This, and the geometric means for all PFAS are shown in 
Supplemental Table 8. Finally, as most of the shorter chain PFAS were 
below the LOD, we report descriptive statistics for all PFAS for in-
dividuals that were above LOD in Supplemental Table 9. 
Next, we determined the percent change over time of log trans-
formed PFAS and utilized 2-sided matched paired t-tests to determine if 
these temporal changes between ACHS I and ACHS II were significantly 
different. In Table 1 we present descriptive statistics for all participants 
we had sufficient leftover serum for separately for ACHS I and II (n =
297 and n = 336 respectively). When we compared the change between 
the two studies, only matched data were used (n = 297). PFOS (51.8% 
decrease), 4.2 FTS (6.12% decrease), PFNA (39.0% decrease), PFOA 
(47.5% decrease), PFHxS (33.7% decrease), and PFHpA (55.8% 
decrease) all significantly decreased over time (p < 0.05), whereas 
HFPO-DA levels increased by nearly 20%, but did not reach significance 
(p = 0.11). PFBS levels did not significantly change (p = 0.460). Simi-
larly, as log transformation did not robustly normalize PFAS of lower 
abundance, we also used the non-parametric Wilcoxon signed-rank test 
to evaluate changes in non-log-transformed PFAS between ACHS I and 
ACHS II. No differences were observed compared to the results from 
paired t-Tests. 
3.2. PFAS comparisons with national averages 
As summarized visually in Fig. 1 and in table form (Supplemental 
Table 1), mean concentrations of legacy PFAS, especially PFOS, differed 
in individuals participating in ACHS I compared with corresponding 
NHANES 2005–2006 data from the same time period. Specifically, PFOS 
levels were 3.52 times higher in ACHS I compared to NHANES 
2005–2006 (p < 0.001). PFNA levels were about 1.3 times higher in 
ACHS I (p < 0.001). Circulating levels of PFOA and PFHpA were 
significantly lower in ACHS I samples compared to NHANES 2005–2006 
(PFOA:2 times higher in NHANES; p < 0.001; PFHpA, 1.3 times higher 
in NHANES; p < 0.001). No significant difference was observed for 
PFHxS between ACHS I and NHANES (p = 0.114). Although PFBS was 
significantly higher in NHANES 2005–2006, this difference was driven 
primarily by a higher limit of detection. Quantitation of HFPO-DA and 
4.2 FTS was not included in NHANES 2005–2006 because these com-
pounds were not then known to be present in the environment. Com-
parisons between ACHS II and corresponding NHANES 2013–2014 
resulted in similar observations (Supplemental Table 1 and Fig. 1). 
Interestingly, PFOS levels may have decreased at a slower rate than the 
national average as ACHS II concentrations were determined to be 5.86 
times higher than NHANES 2013–2014 (compared to 3.51 times higher 
between ACHS I and NHANES 2005–2006). PFNA remained higher in 
ACHS II (1.2 times) and PFOA remained lower (1.9 times). PFHxS was 
significantly decreased in ACHS II (1.2 times) and PFHpA was signifi-
cantly increased (1.6 times) compared to national averages. However, 
there is no PFAS exposure characterization for ACHS and possible 
sources of PFAS exposure in Anniston AL and their relationship to 
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sources of exposure for the general population are not known. Finally, 
because levels of PFOS were considerably higher than anticipated in 
ACHS I and ACHS II, we re-extracted and quantitated a subset of samples 
from individuals with the highest levels of PFOS along with an equal 
number of randomly selected samples. The R2 values for comparison of 
the two data sets were between 0.98 and 0.86 depending on the PFAS 
(Supplemental Fig. 1). 
We next attempted to determine if the observed differences in PFAS 
levels between national averages and residents of Anniston, Alabama 
were preserved if subjects were stratified by sex, race, or age. Table 2 
shows that the differences between PFOS and PFOA in either ACHS I or 
ACHS II with their corresponding NHANES datasets were, in general, not 
sex specific. However, PFNA was only significantly higher in female 
residents of Anniston (in both ACHS I and ACHS II). Also, in ACHS II, 
PFHxS was significantly lower than in NHANES only in males and 
PFHpA was only significantly increased compared to NHANES in fe-
males. Similarly, PFOS and PFOA differences between ACHS and 
NHANES were not specific to African Americans or Whites (Supple-
mental Table 3). Additionally, although comparisions between White 
and African American subjects was not a focus of this biomonitoring 
study, NHANES levels of PFOS were similar for African Americans and 
Whites but in both ACHS I and ACHS II PFOS levels were ~2 times 
higher in African Americans. Interestingly, in both ACHS I and ACHS II, 
PFNA was only significantly different from corresponding NHANES 
Table 1 
PFAS levels in subjects from Anniston Community Health Surveys I and II.  













PFBS 0.05 ± 0.08  0.04 0.04–1.42 14%    
HFPO-DA 0.05 ± 0.06  0.04 0.04–0.44 4.4%    
4.2 FTS 0.05 ± 0.02  0.04 0.04–0.20 10%    
PFOS 71.1 ± 89.3  47.3 0.14–781 99%    
PFNA 1.69 ± 1.17  1.35 0.03–9.67 99%    
PFOA 2.16 ± 1.12  1.99 0.03–7.53 99%    
PFHxS 2.35 ± 2.72  1.75 0.14–26.3 97%    
PFHpA 0.30 ± 0.52  0.04 0.04–6.67 35%    
ACHS IIb 
PFBS 0.05 ± 0.03  0.04 0.04–0.34 11% − 8.22  0.460  0.246 
HFPO-DA 0.07 ± 0.11  0.04 0.04–1.00 8.9% +19.16  0.115  0.087 
4.2 FTS 0.04 ± 0.01  0.04 0.04–0.13 4.8% − 6.12  0.036  0.007 
PFOS 34.7 ± 59.8  18.0 0.14–688 98% − 51.8  <0.001  <0.001 
PFNA 1.04 ± 0.95  0.882 0.03–8.89 97% − 39.0  <0.001  <0.001 
PFOA 1.16 ± 0.90  0.963 0.03–6.44 97% − 47.5  <0.001  <0.001 
PFHxS 1.62 ± 2.55  1.17 0.14–35.6 96% –33.7  <0.001  <0.001 
PFHpA 0.13 ± 0.35  0.04 0.04–5.13 17% − 55.8  <0.001  <0.001 
PFBS = Perfluorobutanesulfonic acid; HFPO-DA = Hexafluoropropylene oxide dimer acid; 4.2 FTS = 4:2 Fluorotelomer sulfonic acid; PFOS = Perfluorooctane sul-
fonate; PFNA = perfluorononanoate; PFHxS = Perfluorohexane sulfonate; PFHpA = perfluoroheptanoic acid. 
PFAS concentrations were not lipid adjusted. 
LODs: PFBS, HFPO-DA, 4.2 FTS, PFHpA = 0.05 ng/mL; PFOA, PFNA = 0.04 ng/mL; PFOS, PFHxS = 0.20 ng/mL 





a Total sample size n = 297 was used for descriptive statistics. 
b Total sample size = 336 was used for descriptive statistics. 
* Delta from ACHS I and associated p-values are based on mean differences and matched paired t-tests using log transformed data (x + 1). A bold p-value denotes 
significant differences for a specific PFAS between ACHS I and ACHS II (n = 294). 
# Determined a significant change from ACHS I by nonparametric Wilcoxon signed-rank test (WSRT) using non log transformed data (n = 294). 



















































Fig. 1. Summary of mean PFAS levels in ACHS I, 
ACHS II, and comparison to NHANES. Total avail-
able samples sizes were used for this summary 
figure. Please see supplemental Table 1 for variances 
and statistical comparisons. PFBS = Per-
fluorobutanesulfonic acid; PFOS = Perfluorooctane 
sulfonate; PFNA = perfluorononanoate; PFHxS =
Perfluorohexane sulfonate; PFHpA = per-
fluoroheptanoic acid. All PFAS concentrations are 
shown in ng/mL and please note the unique y axis 
for PFOS. NHANES 2005–2006 LODs: PFOA,PFBS, 
PFNA,PFHxS = 0.1 ng/mL, PFOS = 0.2 ng/mL, 
PFHpA = 0.4 ng/mL. NHANES 2013–2014 LODs: All 
0.1 ng/mL. ACHS I and II LODs: PFBS, PFHpA =
0.05 ng/mL; PFOA, PFNA = 0.04 ng/mL; PFOS, 
PFHxS = 0.20 ng/mL.   
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levels in African Americans. In ACHS I, white residents of Anniston, 
Alabama showed significantly lower levels of PFHxS and PFHpA. In 
ACHS II, both races had significantly lower levels of PFHxS, but African 
Americans only exhibited a significant increase in PFHpA compared to 
corresponding NHANES data. Finally, racial differences in PFOS and 
PFOA levels were not specific to older or younger participants (Sup-
plemental Table 2). Using median ages of either NHANES 2005–2006 or 
NHANES 2013–2014 as respective stratification points, we noted that 
higher median levels of PFNA in ACHS I were more pronounced in 
younger subjects. This observation was similar for PFHxS when 
comparing ACHS I and NHANES 2005–2006, but in the opposite di-
rection (lower in younger individuals of ACHS I). For PFHpA, mean 
levels were significantly lower in ACHS I compared to NHANES 
2005–2006 only in younger individuals, whereas mean levels were 
significantly higher in ACHS II compared to NHANES 2013–2014 only in 
older individuals. On the other hand, comparing median levels we 
observed that PFHpA levels are significantly lower in both age groups. 
Overall lower levels of PFHpA were generally observed across both age 
groups. 
Finally, although not a focus of this current biomonitoring study, we 
compared certain demographic/anthropometric parameters and clinical 
data between ACHS I and NHANES 2005–2006 to determine possible 
contributing factors for the observed differences in PFAS levels between 
the two datasets. Total cholesterol, LDL cholesterol, and triglyceride 
levels did not differ considerably between the two datasets, but BMI and 
age were notably different (NHANES mean age; 27.9, mean BMI: 25.1; 
ACHS I mean age: 55.1, mean BMI; 32.0 (data not shown). To attempt to 
account for differences in age, we included age stratified comparisons 
between NHANES and ACH studies as described in the preceding para-
graph and summarized in Supplemental Table 2. 
3.3. PFAS correlations with other POPs 
In general, human biomonitoring studies reveal high correlations 
between congeners of the same classes of chemicals, i.e. PCBs and some 
pesticides. The correlations between different chemical classes depend 
on number of factors (manufacturing, industrial uses or commercial 
applications and consequent releast into the environment) and these 
factors have not yet been comprehensively elucidated for PFAS. We 
examined hierarchical clustering of exposures to different environ-
mental chemcials in ACHS I and ACHS II (Fig. 2). ACHS I data exhibits 
two main clusters, one including highly chlorinated PCB congeners, two 
PFAS analytes – PFBS and 4:2 FTS – and chlorinated pesticides: trans- 
Nonaroclor, oxycholordane, and γ-HCCH. The PCBs on the other side of 
the tree form the other large cluster and the bais for this segregation is 
primarily related to the chlorine substitution groupings. ‘Industrial’ 
PCBs, found in higher levels historically at production and use sites and 
that are consquently commonly observed in serum from both industrial 
workers and the general population, PCBs 74, 99, 118, 138, 153, 187, 
are at the bottom of the tree, tracking with the majority of industrially 
used PFAS: PFOS, PFNA, PFHxS, and PFHpA. Mirex rounds up this 
cluster, which relates most closely to other chlorinated pesticides: hex-
achlorobenzene (HCB), β-HCCH, pp’-DDE, and pp-DDT. The rest of the 
lesser chlorinated PCBs in this cluster (28, 44, 49, 52) are closely related 
to PFOA, op-DDT, and other 5–6 chlorine substituted PCBs 101, 110, 
128, 149, 151 that were also closely related to HFPO-DA. 
Table 2 
Comparisons between ACHS I & ACHS II with corresponding NHANES stratified by sex.  




N Mean (SD) Median (Q1,Q3) N Mean (SD) Median (Q1,Q3) 




728 0.079 (0.066) 0.07 (0.07, 
0.07)  
<0.0001  <0.0001  
2005–2007 Male 88 0.061 (0.15) 0.04 (0.04, 
0.04) 
751 0.081 (0.098) 0.07 (0.07, 
0.07)  
0.2277  <0.0001  




681 0.071 (0.013) 0.07 (0.07, 
0.07)  
<0.0001  <0.0001  








0.0006  <0.0001 
PFOS (ng/mL) 2005–2007 Female 208 71 (93) 46 (27, 72) 728 19 (16) 15 (9.5, 23)  <0.0001  <0.0001  
2005–2007 Male 88 73 (80) 53 (33, 79) 751 27 (20) 22 (15, 32)  <0.0001  <0.0001  
2014 Female 237 33 (60) 16 (7.8, 34) 681 6.3 (6.1) 4.3 (2.6, 8.0)  <0.0001  <0.0001  
2014 Male 91 40 (61) 23 (11, 38) 635 11 (56) 6.7 (4.2, 11)  <0.0001  <0.0001 
PFNA (ng/mL) 2005–2007 Female 208 1.7 (1.2) 1.3 (1.0, 1.9) 728 1.3 (1.3) 0.90 (0.70, 1.4)  <0.0001  <0.0001  
2005–2007 Male 88 1.8 (1.2) 1.5 (1.2, 2.0) 751 1.5 (1.2) 1.2 (0.80, 1.8)  0.1244  <0.0001  
2014 Female 237 1.0 (0.92) 0.87 (0.47, 1.2) 681 0.83 (0.91) 0.6 (0.40, 1.0)  0.0073  <0.0001  
2014 Male 91 1.10 (1.1) 0.95 (0.47, 1.4) 635 0.93 (0.66) 0.8 (0.5, 1.2)  0.1083  0.0073 
PFOA (ng/mL) 2005–2007 Female 208 2.0 (1.1) 1.8 (1.3, 2.5) 728 4.0 (3.2) 3.2 (2.2, 5.0)  <0.0001  <0.0001  
2005–2007 Male 88 2.5 (1.2) 2.4 (1.8, 3.0) 751 5.5 (3.6) 4.7 (3.3, 6.8)  <0.0001  <0.0001  
2014 Female 237 1.1 (0.91) 0.93 (0.45, 1.5) 681 2.3 (3.5) 1.8 (1.1, 2.8)  <0.0001  <0.0001  
2014 Male 91 1.3 (0.87) 1.1 (0.57, 1.8) 635 2.6 (1.5) 2.3 (1.6, 3.4)  <0.0001  <0.0001 
PFHxS (ng/ 
mL) 
2005–2007 Female 208 2.2 (2.9) 1.6 (1.1, 2.3) 728 2.3 (3.1) 1.4 (0.80, 2.8)  0.5522  0.2061  
2005–2007 Male 88 2.7 (2.2) 2.2 (1.5, 3.1) 751 3.3 (3.8) 2.2 (1.3, 3.9)  0.0308  0.8300  
2014 Female 237 1.5 (2.5) 1.1 (0.55, 1.7) 681 1.7 (2.0) 1.1 (0.60, 2.0)  0.1764  0.7031  
2014 Male 91 2.0 (2.6) 1.4 (0.73, 2.5) 635 2.8 (2.9) 2 (1.2, 3.2)  0.0260  0.0023 
PFHpA (ng/ 
mL) 
2005–2007 Female 208 0.30 (0.36) 0.04 (0.04, 
0.59) 
728 0.34 (0.39) 0.28 (0.28, 
0.28)  
0.1705  <0.0001  
2005–2007 Male 88 0.30 (0.78) 0.04 (0.04, 
0.45) 
751 0.38 (0.40) 0.28 (0.28, 
0.28)  
0.3439  <0.0001  
2014 Female 237 0.12 (0.22) 0.04 (0.04, 
0.04) 
681 0.086 (0.061) 0.07 (0.07, 
0.07)  
0.0298  <0.0001  
2014 Male 91 0.16 (0.55) 0.04 (0.04, 
0.04) 
635 0.081 (0.046) 0.07 (0.07, 
0.07)  
0.1893  <0.0001 
The P values for the comparison of medians was based on the WRST. 
*NHANES 2005–2006 LODs: PFOA,PFBS,PFNA,PFHxS = 0.1 ng/mL, PFOS = 0.2 ng/mL, PFHpA = 0.4 ng/mL. NHANES 2013–2014 LODs: All 0.1 ng/mL. 
1 2005–2007 = ACHS I and NHANES 2005–2006; 2014 = ACHS II and NHANES 2013–2014. 
2 P-values are determined using non-log transformed data and designate differences between ACHS I and NHANES 2005–2006 or ACHS II and NHANES 2013–2014. 
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a. ACHS I Tree (n=292) *non-log-transformed; wet-weight not lipid adjusted.
b. ACHS II Tree (n=286) *non-log-transformed; wet-weight not lipid adjusted.
Fig. 2. Hierarchical cluster analyses. a. ACHS I Tree (n = 292) *non-log-transformed; wet-weight not lipid adjusted. b. ACHS II Tree (n = 286) *non-log-transformed; 
wet-weight not lipid adjusted. 
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For ACHS II, there are two major clusters, one including all PBDEs 
(including major congeners 99, 147, 153 and 209) and half of PFAS 
analytes: PFOA, PFHxS, HFPO-DA, and 4.2-FTS; also tracking in this 
group is op’- DDT. All PCBs are on the other side of the cluster tree 
retaining the groupings related to chlorine substitution and industrial 
seen for ACHS I. The ‘industrial’ PCBs (74, 99, 118, 138, 153, 180, 187) 
are at the bottom of the tree tracking with industrially used PFAS – PFNA 
and PFHpA. Mirex and total dioxin TEQ round out this cluster which 
relates most closely to other chlorinated pesticides: trans-Nonachlor, 
oxychlordane hexachlorobenzene (HCB) in one cluster and p,p’-DDT, p, 
p’-DDE, and β-HCCH, in the other. This cluster also included the sole 
polybrominated biphenyl PBB 153 (with t-Nona cluster) and total dioxin 
TEQ (with the DDT/DDE cluster). 
For comparison, we obtained Pearson correlation coefficients to 
contrast with the cluster analyses (Supplemental Tables 4–7). Of all 7 
PFAS analytes, PFOS, PFOA, PFHxS, and PFNA are moderately to highly 
correlated with each other. The highest correlation was showed for 
PFNA with PFOS (r > 0.77) and with PFOA (r > 0.56) in ACHS II. There 
were moderate correlations between PFOA, PFOS, and PFHxS 
(0.37–0.47). Gen X showed a slight correlation with PFOA (r > 0.23), 
and PFBS was slightly correlated to 4:2 FTS (r > 0.26) but in general 
these PFAS correlations to PFOA, PFOS, or PFNA were below 0.2. 
We have included PFOS and PFNA in the correlation tables with 
other POPs (Supplemental Table 4 and Table 6) as those analytes were 
higher in Anniston data vs NHANES. Pesticides showed generally low 
correlations with PFAS (r < 0.15) as did PBDEs (low and negative cor-
relations) - in contrast to cluster analysis. PCB74 and PCB153 showed 
moderate correlations with PFOS and PFNA that were higher than for 
other PCBs and pesticides (Supplemental Table 4). The correlation co-
efficients were slightly lower for ACHS I but in general in agreement 
with ACHS II (PBDEs and dioxins were not measured in ACHS I). For 
PCBs, higher chlorinated PCBs are highly correlated with each other and 
moderately correlated with lower chlorinated PCBs and pesticides. 
Weak or negative correlations were observed among PCBs and PBDEs. 
Total TEQ was also highly correlated with PCBs 74 and 153 (r > 0.84). 
The temporal and spatial groupings and correlations identified in cluster 
analyses are therefore not apparent using only Pearson correlation 
coefficients. 
4. Discussion 
Previously, the Anniston Community Health Survey has shown that 
residents of Anniston, Alabama were highly exposed to polychlorinated 
biphenyls primarily due to long term chemical manufacturing in the 
area (Pavuk et al., 2014). Concurrently, residents may have been 
exposed to other environmental chemicals including pesticides, flame 
retardants, and per-and poly fluoroalkyl substances from unknown ori-
gins, thus a concerted effort has been made to quantitate additional 
pollutants in the original ACHS and follow-up ACHS II studies. Here, we 
report on the concentrations of eight PFAS of varying chain length in 
available samples from these individuals and describe how levels 
changed between the two studies (~8 years), how levels compare to 
national averages at that time, and begin to identify patterns of corre-
lation with other previously measured pollutants in ACHS participants. 
Our findings show that residents of Anniston, Alabama had higher levels 
of PFOS in both ACHS I and ACHS II compared to NHANES levels during 
equivalent time periods. PFOS levels were more than three times higher 
than national averages and PFOS was consistently higher for all the age, 
race, and sex specific strata compared. Residents of Anniston appear to 
also be more highly exposed to PFNA than national averages, but these 
differences for PFNA are much less robust than for PFOS with the dif-
ferences observed depending on how cohorts were stratified based on 
age, sex, or race. All longer chain PFAS decreased over the ~8-year 
period between ACHS studies with these decreases ranging from 
approximately 30 to 50 percent. Emerging short chain PFAS were not 
readily detected, but HFPO-DA did appear to be increasing in abundance 
over time (from 4.4% to 8.9% above LOD). This increase did not reach 
significance with such a small percentage of individuals having levels 
above the LOD, but this observation is important and worthy of further 
investigation in more recent NHANES and other cohorts. Finally, the 
exact exposure sources of PFAS are unknown in this community, but the 
presence of the nearby military installations where PFAS could have 
been used to put out fires or for other purposes as in a number of other 
military installations around the country (ATSDR, 2020) may be a 
source of water contamination in this community. Exposure to aqueous 
film-forming foam (AFFF) contaminants in drinking water may be a 
source of the higher PFOS in ACHS participants, but possibly not PFNA 
(Barton et al., 2020). In a 2014 study of individuals residing near an air 
force base in New Hampshire, geometric mean serum concentrations of 
PFOS, PFOA, and PFHxS were 8.6 ng/mL (95% CI:8.3–8.9), 3.1 ng/mL 
(95% CI: 3.0–3.2), and 4.1 ng/mL (95% CI: 3.9–4.3), respectively which 
does not mirror what we see in Anniston (Daly et al., 2018). However, 
AFFF is also a source of PFOA, which is not higher in ACHS. There are 
also reports of additional areas of high PFAS exposure in Alabama (i.e., 
Decatur) where manufacturing and transport did occur (Worley et al., 
2017). Dietary questionnaire information for ACHS was limited to 
evaluation of local foods potentially contaminated with PCBs and had 
little explanatory value for our study of PFAS exposures. Also, the 
available occupational information only asked about potential for other 
exposure to metals, acids, pesticides; thus, further studies of the expo-
sure routes of PFAS in ACHS participants are warranted. 
Quantitation of PFAS in matched samples over time is an important 
means of estimating biological elimination as well as identifying expo-
sure trends over time. Previous reports have shown that longer chain 
PFAS such as PFNA are more bioaccumulative than PFAS of shorter 
chain lengths and sulfonates may be more bioaccumulative than car-
boxylates (Donat-Vargas et al., 2019). Exceptions include PFHxS which 
can be considered a shorter chain or longer chain PFAS, depending on 
the chain length cutoff used, and may have a longer half-life than PFOS. 
Some prior studies have attempted to estimate half-lives of PFAS, but the 
values reported are highly variable which may be a consequence of large 
differences in initial exposure level and the use of different toxicokinetic 
elimination models (Fu, 2016). In our study, percentage decreases over 
the ~8 year period were highest for PFHpA, PFOS, and PFOA (all around 
50% decrease) and lowest for PFHxS (approximately 30% decrease). 
Our observed decreases in PFOS and PFOA were similar to other studies 
of similar timeframe (Worley et al., 2017). Focusing on PFOS, another 
study of Gullah African Americans from coastal South Carolina showed 
that PFOS dropped approximately nine percent each year between 2003 
and 2013 (Gribble et al., 2015) which is consistent with our observations 
in residents of Anniston, Alabama. Finally, it is hard to interpret and 
compare our observations of possibly increased circulating levels of 
HFPO-DA over time because few studies in the United States focusing on 
matched serum samples have reported on HFPO-DA levels using 
analytical methodologies with comparable LODs. It will be important for 
future NHANES datasets to quantitate HFPO-DA and other emerging 
short chain PFAS in serum of participants. 
In the original ACHS study there were important sex-, age-, and race- 
related differences between PCB concentrations (Pavuk et al., 2014). 
Multiple factors including residential proximity to the manufacturing 
plant, length of residence in the area, and dietary or cultural behaviors 
(e.g. local fish consumption, geophagia) explained some of the variation 
in PCB exposures but the main differences associated with to age and 
race remained (Pavuk et al., 2014). Here, when we stratified our com-
parisons to national averages based on these demographic parameters, 
we did not see many obvious differences for most of the PFAS we 
measured. For example, residents of Anniston, Alabama had higher 
levels of PFOS at both time points when we compared age, race, and sex 
matched individuals from NHANES. We note that male residents of 
Anniston had higher levels of PFAS than females and older residents had 
higher levels than younger (Supplemental Table 10). PFAS can be 
eliminated during menstruation and nursing which may play a role in 
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these sexual dimorphisms (Park et al., 2019). There is some evidence 
that women excrete PFOS and PFHxS more quickly than males, but in 
our population these differences were marginal at about 10% difference 
between sexes (Li et al., 2018). Finally, African Americans had higher 
levels of PFOS than Whites in this study population, which was not seen 
in the NHANES data (Supplemental Table 10). African Americans were 
also more highly exposed to PCBs in comparison to White subjects (26) 
and in ACHS II the mean sum of all PCBs measured was 2–3 times higher 
in African American subjects than White subjects across all ages (33). 
While the explanation for these differences is not firmly established, 
some possibilities have been suggested and these could contribute to the 
differences in PFOS exposure we report here. While all subjects live in 
West Anniston, African American subjects mostly live closer to the site of 
the former PCB manufacturing facility and the waterway running away 
from it which is at lower elevation than other parts of Anniston AL and 
has higher soil levels of PCBs. In comparison to white subjects, a larger 
portion of African American subjects reported consumption of local fish 
and livestock and eating local clay. Self-reported responses to questions 
designed to capture possible occupational exposure to PCBs or other 
environmental chemicals did not reveal obvious differences between 
African American and White subjects. We therefore suggest the possi-
bility that, as with PCBs, geographic residential location and possibly 
dietary sources of exposure could account for or contribute to the 
observed differences in PFOS exposure between African American and 
White subjects. Clearly further investigation is needed which could 
include the possibility that surface or drinking water are sources of PFAS 
exposure that also contribute to these racial differences. 
Examining correlations between circulating pollutants may lead to a 
better understanding of common exposure routes in a community. In 
previous studies, levels of different PFAS have shown highly heteroge-
nous patterns of collinearity. For example, in one study PFOS signifi-
cantly correlated with PFHxS with a correlation coefficient of 0.30 (Fry 
and Power, 2017) but in a separate study PFOS significantly correlated 
with PFHxS with a stronger correlation coefficient of 0.75 (Watkins 
et al., 2019). Similar variability in observations was seen between cor-
relations of PFOS and PFNA in these studies. Here, we show that PFNA 
was strongly correlated with PFOS with correlation coefficients nearing 
0.80, and this correlation was seen in both ACHS I and ACHS II. Other 
correlations were observed, but at weak to moderate levels. HFPO-DA 
showed slight correlation with PFOA which is interesting as HFPO-DA 
is a replacement for PFOA as a polymer processing aid for PTFE pro-
duction. Finally, there are only a few published reports investigating 
correlations between PFAS levels and other legacy pollutants such as 
PCBs, pesticides, and PBDEs. It is well established that congeners of 
similar legacy pollutants regularly show strong correlations with each 
other, but less is known how concentrations of PCBs and other POPs 
relate to PFAS. In one study the summed total of PCBs correlated weakly 
with PFOS with a correlation coefficient of 0.27 and no correlation be-
tween PCBs and PFOA was observed (Petersen et al., 2018). Here, pes-
ticides showed generally low correlations with PFAS (r < 0.15) as did 
PBDEs (low and negative correlations). PCB74 and PCB153 showed 
moderate correlations with PFOS and PFNA that were higher than for 
other PCBs and pesticides (Table S3). The correlations coefficients were 
slightly lower for ACHS I but in general in agreement with ACHS II. 
There are multiple strengths and some weaknesses of this work. The 
strengths are that the analytical measurements of POPs previously re-
ported, and now PFAS, are technically robust and well validated. Also, 
the longitudinal nature of the two studies over an approximately 8-year 
timeframe allows statistical analyses for matched pairs to be completed 
and useful estimates of percent decrease over time to be made. Finally, 
we believe this to be one of the few studies that report correlation pat-
terns between a wide variety of POPs including PCBs, PFAS, PBDEs, and 
pesticides. In our study we observed PFOS levels to be higher in residents 
of Anniston, Alabama compared to age, sex, and race matched in-
dividuals within NHANES of corresponding years. A weakness of our 
study is that these conclusions should be viewed with caution due to 
differences in age, sex, and other demographics between NHANES and 
ACHS subjects. For example, both ACHS I and ACHS II were predomi-
nately older females of higher BMI; PFAS did significantly positively 
associate with age in ACHS, but not with BMI (supplemental Fig. 3). 
Also, although we did not observe differences in age stratified compar-
isons with NHANES, especially with PFOS, the age differences between 
the cohorts (NHANES includes children aged 12–18 while no ACHS 
subjects are younger than 19) could account for or contribute to some 
observed differences (supplemental Fig. 2). Additionally, in the 
NHANES years that corresponded to ACHS I and ACHS II, no serum 
levels of HFPO-DA or 4.2-FTS were quantitated which limits available 
comparisons. In the NHANES 2013–2014 dataset, HFPO-DA was only 
quantitated in urine samples, and nearly all samples were below the 
limit of detection (data not shown) so worthwhile statistical compari-
sons with ACHS II cannot be made. As a point of reference however, 
serum HFPO-DA was quantitated above the LOD in 8.9% of individuals 
within ACHS II compared to only 1.13% of individuals in urine in 
NHANES 2013–2014; although the limits of detection are slightly be-
tween the two studies (ACHS II; 0.05 ng/mL, NHANES; 0.07 ng/mL). 
Because the LODs in serum and urine are not directly comparable and 
the relationship between HFPO-DA in serum and excreted in urine is not 
well understood these differences should be considered preliminary. 
Simiarly, although we report on PFHpA and PFBS differences between 
ACHS and corresponding NHANES, these pollutants were not widely 
detected in ACHS subjects, so differences between ACHS and NHANES 
should be considered exploratory. Finally, there is some evidence that 
certain health outcomes such as liver disease may impact on circulating 
PFAS (Yeung et al., 2013), and there are reports of pollutant-associated 
liver disease and hyperlipidemia in ACHS (Clair et al., 2018; Aminov, 
2013). 
5. Conclusions 
Residents of Anniston, Alabama were highly exposed to PCBs due to 
longstanding manufacturing in the area, and here we report that these 
same individuals simultaneously had high circulating levels of PFOS, 
and to a lesser-degree, PFNA. Future studies identifying associations 
between clinical parameters and health outcomes with PFAS exposure in 
this longitudinal cohort may also identify important synergistic in-
teractions between legacy and emerging persistent organic pollutants. 
The higher levels of PFOS and PFNA found in African Americans 
compared to Whites within the ACHS study population points to a need 
for future investigations to identify sources of PFAS exposure in these 
subjects. 
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Pavuk, M., Olson, J.R., Sjödin, A., Wolff, P., Turner, W.E., Shelton, C., Dutton, N.D., 
Bartell, S., 2014. Serum concentrations of polychlorinated biphenyls (PCBs) in 
participants of the Anniston Community Health Survey. Sci. Total Environ. 473-474, 
286–297. 
Olsen, G.W., Mair, D.C., Lange, C.C., Harrington, L.M., Church, T.R., Goldberg, C.L., 
Herron, R.M., Hanna, H., Nobiletti, J.B., Rios, J.A., Reagen, W.K., Ley, C.A., 2017. 
Per- and polyfluoroalkyl substances (PFAS) in American Red Cross adult blood 
donors, 2000–2015. Environ. Res. 157, 87–95. 
Birnbaum, L.S., Dutton, N.D., Cusack, C., Mennemeyer, S.T., Pavuk, M., 2016. Anniston 
community health survey: Follow-up and dioxin analyses (ACHS-II)–methods. 
Environ. Sci. Pollut. Res. Int. 23 (3), 2014–2021. 
Mottaleb, M.A., Petriello, M.C., Morris, A.J., 2020. High-throughput UHPLC-MS/MS 
measurement of per- and poly-fluorinated alkyl substances in human serum. J. Anal. 
Toxicol. 44 (4), 339–347. 
Anderberg, M.R., 1973. Cluster Analysis for Applications. Academic Press Inc., New 
York.  
Hand, D.J., Daly, F., Lunn, A.D., McConway, K.J., Ostrowski, E. (Eds.), 1994. 
A Handbook of Small Data Sets. Chapman & Hall, London.  
Harman, H.H., 1976. Modern Factor Analysis, third ed. University of Chicago Press, 
Chicago.  
Harris, C.W., Kaiser, H.F., 1964. Oblique factor analytic solutions by orthogonal 
transformation. Psychometrika 32, 363–379. 
Barton, K.E., Starling, A.P., Higgins, C.P., McDonough, C.A., Calafat, A.M., Adgate, J.L., 
2020. Sociodemographic and behavioral determinants of serum concentrations of 
per- and polyfluoroalkyl substances in a community highly exposed to aqueous film- 
forming foam contaminants in drinking water. Int. J. Hyg. Environ. Health 223 (1), 
256–266. 
Daly, E.R., Chan, B.P., Talbot, E.A., Nassif, J., Bean, C., Cavallo, S.J., Metcalf, E., 
Simone, K., Woolf, A.D., 2018. Per- and polyfluoroalkyl substance (PFAS) exposure 
assessment in a community exposed to contaminated drinking water, New 
Hampshire, 2015. Int. J. Hyg. Environ. Health 221 (3), 569–577. 
Worley, R.R., Moore, S.M., Tierney, B.C., Ye, X., Calafat, A.M., Campbell, S., 
Woudneh, M.B., Fisher, J., 2017. Per- and polyfluoroalkyl substances in human 
serum and urine samples from a residentially exposed community. Environ. Int. 106, 
135–143. 
Donat-Vargas, C., Bergdahl, I.A., Tornevi, A., Wennberg, M., Sommar, J., Koponen, J., 
Kiviranta, H., Åkesson, A., 2019. Associations between repeated measure of plasma 
perfluoroalkyl substances and cardiometabolic risk factors. Environ. Int. 124, 58–65. 
Gribble, M.O., Bartell, S.M., Kannan, K., Wu, Q., Fair, P.A., Kamen, D.L., 2015. 
Longitudinal measures of perfluoroalkyl substances (PFAS) in serum of Gullah 
African Americans in South Carolina: 2003–2013. Environ. Res. 143, 82–88. 
Pavuk, M., Olson, J.R., Wattigney, W.A., Dutton, N.D., Sjödin, A., Shelton, C., Turner, W. 
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